References & Sources  - October 17, 1998

<Back to Contents

Diabetes drug stirs cancer confusion

Though troglitazone may thwart human colon cancer in some cases, the widely prescribed drug may also trigger the cancer in genetically susceptible people.

 

References:

Lefebvre, A.-M. . . . J. Awerx. 1998. Activation of the peroxisome proliferator-activated receptor g promotes the development of colon tumors in C57BL/6J-APC^Min/+mice. Nature Medicine 4(September):1053.

Saez, E. . . . R.M. Evans. 1998. Activators of the nuclear receptor PPARg enhance colon polyp formation. Nature Medicine 4(September):1058.

Sarraf, P. . . . B.M. Spiegelman. 1998. Differentiation and reversal of malignant changes in colon cancer through PPARg . Nature Medicine 4(September):1046.

Seed, B. 1998. PPARg and colorectal carcinoma: Conflicts in a nuclear family. Nature Medicine 4(September):1004.

 

Sources:

Ronald M. Evans
Howard Hughes Medical Institute
Salk Institute for Biological Studies
La Jolla, CA 92037

Bruce M. Spiegelman
Dana-Farber Cancer Institute
Department of Cell Biology
Harvard Medical School
Boston, MA 02115

From Science News, Vol. 154, No. 16, October 17, 1998, p. 250.
Copyright Ó 1998 by Science Service.

Back to Table of Contents - 10/17/98